Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Leishmania Vaccines Entered in Clinical Trials: A Review of Literature Publisher



Moafi M1 ; Sherkat R2 ; Taleban R3 ; Rezvan H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pathobiology, Faculty of Veterinary Science, Bu-Ali Sina University, Hamedan, Iran
  2. 2. Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2019


Abstract

Leishmaniasis is considered as a zoonotic infection and neglected tropical disease. Leishmania treatment is not totally successful and imposes high expenditures, especially in developing countries. Since the natural infection leads to the robust immunity in most of the human cases, many bodies of research have been focusing on Leishmania vaccines, being capable to control Leishmania infection. First generation vaccines (such as Leishmune and CaniLeish) have proved robust protective immunity in dogs. In human, recombinant vaccines, including Leish-F1 could confer some degrees of protective immunity against natural infection. Recently, ChAd63-KH DNA vaccine has been accomplished in providing prevention against Leishmania infection; however, this vaccine should be further evaluated in other clinical trials. © 2019 International Journal of Preventive Medicine.
Related Docs
View other Related Docs
1. Vaccination in Leishmaniasis: A Review Article, Iranian Biomedical Journal (2022)
2. Bioinformatics Analysis for the Purpose of Designing a Novel Multi-Epitope Dna Vaccine Against Leishmania Major, Scientific Reports (2022)
3. Comparison of Protein Profile of Killed and Autoclaved Leishmania Major Using Polyacrylamide Gel Electrophoresis, Journal of Isfahan Medical School (2013)
4. From Classical Approaches to New Developments in Genetic Engineering of Live Attenuated Vaccine Against Cutaneous Leishmaniasis: Potential and Immunization, Frontiers in Public Health (2024)
5. Induction of Immune Responses by Dna Vaccines Formulated With Dendrimer and Poly (Methyl Methacrylate) (Pmma) Nano-Adjuvants in Balb/C Mice Infected With Leishmania Major, Open Access Macedonian Journal of Medical Sciences (2018)
6. Immunoinformatic Approach to the Design of a Novel Multi-Epitope Vaccine Against Leishmania Major Fused to Human Igg-Fc, Research in Pharmaceutical Sciences (2024)
7. Evaluation of Live Recombinant Nonpathogenic Leishmania Tarentolae Expressing Cysteine Proteinase and A2 Genes As a Candidate Vaccine Against Experimental Canine Visceral Leishmaniasis, PLoS ONE (2015)
8. Immunological Comparison of Dna Vaccination Using Two Delivery Systems Against Canine Leishmaniasis, Veterinary Parasitology (2015)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Hejazi (26)
Hossein Khanahmad (10)
Other Related Docs
9. Combinatorial Delivery of Antigen and Tlr Agonists Via Plga Nanoparticles Modulates Leishmania Major-Infected-Macrophages Activation, Biomedicine and Pharmacotherapy (2021)
10. A Lentiviral Vaccine Expressing Kmp11-Haspb Fusion Protein Increases Immune Response to Leishmania Major in Balb/C, Parasitology Research (2018)
11. Immunization Against Leishmania Major Using Uv-Irradiated Promastigote in Experimental Model Balb/C Mice, Biochemical and Cellular Archives (2017)
12. Leishmanization: Use of an Old Method for Evaluation of Candidate Vaccines Against Leishmaniasis, Vaccine (2005)
13. Engineering a Multi-Epitope Vaccine Candidate Against Leishmania Infantum Using Comprehensive Immunoinformatics Methods, Biologia (2022)
14. Exposure to Leishmania Major Modulates the Proportion of Cd4+ T Cells Without Affecting Cellular Immune Responses, Microbiology and Immunology (2007)
15. A Comprehensive Review on Various Aspects of Sars-Cov-2 (Covid-19) Vaccines, International Journal of Preventive Medicine (2022)
16. The Role of Bax in the Apoptosis of Leishmania-Infected Macrophages, Microbial Pathogenesis (2020)
17. Immunology and Genetic of Leishmania Infantum: The Role of Endonuclease G in the Apoptosis, Journal of Research in Medical Sciences (2018)
18. Regulatory T-Cell Profile in Early and Late Lesions of Cutaneous Leishmaniasis Due to Leishmania Major, Journal of Isfahan Medical School (2014)
19. Evaluation of Transgenic Leishmania Infantum Expressing Mllo-Bax-Smac in the Apoptosis of the Infected Macrophages in Vitro and in Vivo, Parasite Immunology (2020)
20. Identification of Leishmania Species and Treatment Courses in Patients With Leishmaniasis in Isfahan, Iran, Journal of Isfahan Medical School (2012)
21. The Potential Role of Protein Disulfide Isomerases (Pdis) During Parasitic Infections: A Focus on Leishmania Spp., Pathogens and Disease (2023)
22. Detection of Leishmania Parasites From Cutaneous Leishmaniasis Patients With Negative Direct Microscopy Using Nnn and Pcr-Rflp, Journal of Isfahan Medical School (2012)
23. Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of Balb/C Mice Caused by Leishmania Major, Acta Parasitologica (2021)
24. Cloning of Iranian Leishmania Major Mannose-1-Phosphate Guanyltransferase Gene, African Journal of Biotechnology (2009)
25. Therapeutic Effect of Topical Tamoxifen in Murine Cutaneous Leishmaniasis Caused by Leishmania Major, Antimicrobial Agents and Chemotherapy (2024)
26. A Randomised, Double-Blind, Controlled Trial of a Killed L. Major Vaccine Plus Bcg Against Zoonotic Cutaneous Leishmaniasis in Iran, Vaccine (1999)
27. An Outbreak of Cutaneous Leishmaniasis Due to Leishmania Major in an Endemic Focus in Central Iran, Journal of Parasitic Diseases (2022)
28. Nramp1 Gene Polymorphisms and Cutaneous Leishmaniasis: An Evaluation on Host Susceptibility and Treatment Outcome, Journal of Vector Borne Diseases (2016)
29. Comparative Molecular Epidemiology of Leishmania Major and Leishmania Tropica by Pcr-Rflp Technique in Hyper Endemic Cities of Isfahan and Bam, Iran, Case Reports and Clinical Practice Review (2010)
30. Comparative Molecular Epidemiology of Leishmania Major and Leishmania Tropica by Pcr-Rflp Technique in Hyper Endemic Cities of Isfahan and Bam, Iran, Medical Science Monitor (2010)
31. Anti-Leishmaniasis Effect of Staphylococcus Aureus Protein a on the Size of the Lesion and Parasitic Load, Advanced Biomedical Research (2023)
32. Regulatory T-Cell Profile in Early and Late Lesions of Cutaneous Leishmaniasis Due to Leishmania Major, Journal of Research in Medical Sciences (2012)
33. Effect of Acupuncture Treatment on Level of Serum Interferon (Ifn)-Γ in Balb/C Model of Leishmania Major Infection, Journal of Isfahan Medical School (2013)
34. Immune Response Measured in Human Volunteers Vaccinated With Autoclaved Leishmania Major Vaccine Mixed With Low Dose of Bcg, Clinical and Experimental Immunology (2003)
35. Randomised Vaccine Trial of Single Dose of Killed Leishmania Major Plus Bcg Against Anthroponotic Cutaneous Leishmaniasis in Bam, Iran, Lancet (1998)
36. Genetic Analysis of Clinical Isolates of Leishmania Major From Isfahan, Iran, Journal of Vector Borne Diseases (2012)
37. Effect of Leishmania Gerbilli Injection on Mice Immunization Against Cutaneous Leishmaniasis (Cl) Caused by Leishmania Major, Pakistan Journal of Biological Sciences (2007)
38. Molecular Identification of Leishmania Species in Phlebotomus Alexandri (Diptera: Psychodidae) in Western Iran, Journal of Arthropod-Borne Diseases (2020)
39. The Role of Bcg in Human Immune Responses Induced by Multiple Injections of Autoclaved Leishmania Major As a Candidate Vaccine Against Leishmaniasis, Vaccine (2002)
40. Cloning of Mannose-1-Phosphate Guanyltransferase Encoding Gene (Mrho/Ir/Er/75) in Leishmania Major, Journal of Isfahan Medical School (2009)
41. The Comparison of the Ifn-ɤ, Tnf-Α and Il-10 Cytokines in Healing and Non-Healing Cutaneous Leishmaniasis, Iranian Journal of Parasitology (2021)
42. Gene Cloning of Iranian Leishmania Major Mannose-1-Phosphate Guanyltransferase, Iranian Journal of Parasitology (2009)
43. Evaluation of a Novel Lentiviral Vaccine Expressing Kmp11-Haspb Fusion Protein Against Leishmania Infantum in Balb/C Mice, Parasite Immunology (2016)
44. Evaluation of Il-12Rb1, Il-12B, Cxcr-3 and Il-17A Expression in Cases Affected by a Non-Healing Form of Cutaneous Leishmaniasis: An Observational Study Design, BMJ Open (2017)
45. The Effects of Prednisolone and Mometasone on Wound Healing Caused by Leishmania Major in Balb/C Mice, Journal of Isfahan Medical School (2020)
46. Effect of Transgenic Leishmania Major Expressing Mllo-Bax-Smac Fusion Gene in the Apoptosis of the Infected Macrophages, Iranian Journal of Basic Medical Sciences (2021)
47. Genetic Diversity of Leishmania Major Strains Isolated From Phlebotomus Papatasi and Phlebotomus Alexandri in Western Iran Based on Minicircle Kdna, Journal of Parasitic Diseases (2021)
48. Identification and Phylogenic Analysis of Leishmania Species Among Patients and Reservoir Hosts Based on N-Acetylglucosamine-1-Phosphate Transferase Gene in Central Iran, Annals of Parasitology (2022)
49. Transmission of Leishmania Infantum by Rhipicephalus Sanguineus (Acari: Ixodidae) in Dogs, Iranian Journal of Parasitology (2017)
50. Rhomboid Antigens Are Promising Targets in the Vaccine Development Against Toxoplasma Gondii, EXCLI Journal (2019)